ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Frank W. Sellke
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sato, K.
Right arrow Articles by Post, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sato, K.
Right arrow Articles by Post, M. J.
Related Collections
Right arrowRelated Article

Ann Thorac Surg 2000;70:2113-2118
© 2000 The Society of Thoracic Surgeons

Original article: cardiovascular

Efficacy of intracoronary versus intravenous FGF-2 in a pig model of chronic myocardial ischemia

Kaori Sato, MDa,b, Roger J. Laham, MDa,b, Justin D. Pearlman, MD, PhDa,b, Deborah Novicki, PhDa,b, Frank W. Sellke, MDa,b, Michael Simons, MDa,b, Mark J. Post, MD, PhDa,b

a Angiogenesis Research Center, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA
b Chiron Corporation, Emeryville, California, USA

Address reprint requests to Dr Post, Angiogenesis Research Center, Beth Israel Deaconess Medical Center, 330 Brookline Ave, Boston, MA 02215
e-mail: mpost{at}caregroup.harvard.edu

Presented at the Poster Session of the Thirty-sixth Annual Meeting of The Society of Thoracic Surgeons, Fort Lauderdale, FL, Jan 31–Feb 2, 2000.

Background. Therapeutic angiogenesis in ischemic myocardium has been shown to be a feasible and effective strategy to improve regional blood flow and myocardial function. However, the optimal mode of growth factor administration still needs to be established.

Methods. Using a pig model of chronic myocardial ischemia, we evaluated the efficacy of intravenous and intracoronary infusion of FGF-2 at 2 and 6 µg/kg compared with a vehicle control. Improvement in myocardial perfusion and function was assessed by angiography, colored microspheres, and function and perfusion magnetic resonance imaging.

Results. Intracoronary 6-µg/kg FGF-2 increased angiographic collaterals (p = 0.046) and increased regional blood flow to the ischemic area from 0.36 ± 0.07 to 0.59 ± 0.08 mL/min/g at stress (vs control, p = 0.032). Also, after 6 µg/kg intracoronary FGF-2, ejection fraction, regional wall motion, and thickening improved significantly by 9.9% ± 1.9%, 126% ± 39%, and 13.8% ± 3.6%, respectively. Intravenous FGF-2 and intracoronary 2 µg/kg FGF-2 were ineffective.

Conclusions. A single 6-µg/kg intracoronary treatment with FGF-2 resulted in significant improvement in collateralization and regional and global function of chronically ischemic myocardium. Single intravenous infusion of FGF-2 was not effective in this model.


Related Article

Invited commentary
Todd Rosengart
Ann. Thorac. Surg. 2000 70: 2118. [Extract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
 Ann. Thorac. Surg.Home page
T. M. Yau, C. Kim, G. Li, Y. Zhang, S. Fazel, D. Spiegelstein, R. D. Weisel, and R.-K. Li
Enhanced Angiogenesis With Multimodal Cell-Based Gene Therapy
Ann. Thorac. Surg., March 1, 2007; 83(3): 1110 - 1119.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
M. J. Post, K. Sato, M. Murakami, J. Bao, D. Tirziu, J. D. Pearlman, and M. Simons
Adenoviral PR39 improves blood flow and myocardial function in a pig model of chronic myocardial ischemia by enhancing collateral formation
Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2006; 290(3): R494 - R500.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol PatholHome page
S. U. Lee, J. J. Wykrzykowska, and R. J. Laham
Angiogenesis: Bench to Bedside, Have We Learned Anything?
Toxicol Pathol, January 1, 2006; 34(1): 3 - 10.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
S. F. Vatner
FGF Induces Hypertrophy and Angiogenesis in Hibernating Myocardium
Circ. Res., April 15, 2005; 96(7): 705 - 707.
[Full Text] [PDF]

Home page
 Cardiovasc ResHome page
J. E. Markkanen, T. T. Rissanen, A. Kivela, and S. Yla-Herttuala
Growth factor-induced therapeutic angiogenesis and arteriogenesis in the heart-gene therapy
Cardiovasc Res, February 15, 2005; 65(3): 656 - 664.
[Abstract] [Full Text] [PDF]

Home page
 Exp PhysiolHome page
N. M. Degabriele, U. Griesenbach, K. Sato, M. J. Post, J. Zhu, J. Williams, P. K. Jeffery, D. M. Geddes, and E. W. F. W. Alton
Critical appraisal of the mouse model of myocardial infarction
Exp Physiol, July 1, 2004; 89(4): 497 - 505.
[Abstract] [Full Text] [PDF]

Home page
 Eur. J. Cardiothorac. Surg.Home page
L. Barandon, T. Couffinhal, P. Dufourcq, J. Ezan, P. Costet, D. Daret, C. Deville, and C. Duplaa
Frizzled A, a novel angiogenic factor: promises for cardiac repair
Eur. J. Cardiothorac. Surg., January 1, 2004; 25(1): 76 - 83.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
M. H. Kown, T. Suzuki, M. L. Koransky, K. Penta, G. Sakamoto, C. L. Jahncke, A. J. Carter, T. Quertermous, and R. C. Robbins
Comparison of developmental endothelial locus-1 angiogenic factor with vascular endothelial growth factor in a porcine model of cardiac ischemia
Ann. Thorac. Surg., October 1, 2003; 76(4): 1246 - 1251.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
G. von Degenfeld, P. Raake, C. Kupatt, C. Lebherz, R. Hinkel, F. J. Gildehaus, W. Munzing, A. Kranz, J. Waltenberger, M. Simoes, et al.
Selective Pressure-Regulated retroinfusion of fibroblast growth factor-2 into the coronary vein enhances regional myocardial blood flow and function in pigs with chronic myocardial ischemia
J. Am. Coll. Cardiol., September 17, 2003; 42(6): 1120 - 1128.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
G. C. Hughes, M. J. Post, M. Simons, and B. H. Annex
Translational Physiology: Porcine models of human coronary artery disease: implications for preclinical trials of therapeutic angiogenesis
J Appl Physiol, May 1, 2003; 94(5): 1689 - 1701.
[Abstract] [Full Text] [PDF]

Home page
 Card Surg AdultHome page
M. Ruel, R. A. Kelly, and F. W. Sellke
Therapeutic Angiogenesis, Transmyocardial Laser Revascularization, and Cell Therapy
Card. Surg. Adult, January 1, 2003; 2(2003): 715 - 750.
[Full Text]

Home page
 Ann. Thorac. Surg.Home page
J.-Y. Min, M. F. Sullivan, Y. Yang, J.-P. Zhang, K. L. Converso, J. P. Morgan, and Y.-F. Xiao
Significant improvement of heart function by cotransplantation of human mesenchymal stem cells and fetal cardiomyocytes in postinfarcted pigs
Ann. Thorac. Surg., November 1, 2002; 74(5): 1568 - 1575.
[Abstract] [Full Text] [PDF]

Home page
 Ann. N. Y. Acad. Sci.Home page
M. J. POST
Angiogenesis: Initiation and Maintenance
Ann. N.Y. Acad. Sci., June 1, 2002; 961(1): 249 - 250.
[Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
M. Simons
Therapeutic coronary angiogenesis: a fronte praecipitium a tergo lupi?
Am J Physiol Heart Circ Physiol, May 1, 2001; 280(5): H1923 - H1927.
[Full Text] [PDF]

Home page
 CirculationHome page
M. Simons, B. H. Annex, R. J. Laham, N. Kleiman, T. Henry, H. Dauerman, J. E. Udelson, E. V. Gervino, M. Pike, M.J. Whitehouse, et al.
Pharmacological Treatment of Coronary Artery Disease With Recombinant Fibroblast Growth Factor-2: Double-Blind, Randomized, Controlled Clinical Trial
Circulation, February 19, 2002; 105(7): 788 - 793.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2000 by The Society of Thoracic Surgeons.